|
1
|
Finucane MM, Danaei G and Ezzati M:
Bayesian estimation of population-level trends in measures of
health status. Statistical Sci. 29:18–25. 2014. View Article : Google Scholar
|
|
2
|
Palomer X, Barroso E, Zarei M, Botteri G
and Vázquez-Carrera M: 2PPARβ/δ and lipid metabolism in the heart.
Biochim Biophys Acta. 1860:1569–1578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tuttolomondo A, Maida C and Pinto A:
Diabetic foot syndrome: Immune-inflammatory features as possible
cardiovascular markers in diabetes. World J Orthop. 6:62–76. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krylova NV, Popov AM and Leonova GN:
Antioxidants as potential antiviral agents for flavivirus
infections (Review). Antibiotiki i Khimioterapiya. 61:25–31.
2016.(In Russian).
|
|
5
|
Krivoshapko ON, Popov AM, Artyukov AA and
Kostetskiĭ EIa: Features of corrective actions polar lipids from
marine and aquatic bioantioxidants in disorders of lipid and
carbohydrate metabolism. Biomed Khim. 58:189–198. 2012.(In
Russian). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krivoshapko ON and Popov AM: Curative and
preventive properties of lipids and antioxidants isolated from
marine hydrobionts. Vopr Pitan. 80:4–8. 2011.(In Russian).
PubMed/NCBI
|
|
7
|
Popov AM and Krivoshapko ON: Protective
Effects of Polar Lipids and Redox-active compounds from marine
organisms at modeling of hyperlipidemia and diabetes. J Biomed Sci
Eng. 6:543–550. 2013. View Article : Google Scholar
|
|
8
|
Popov AM, Krivoshapko ON and Artyukov AA:
Protective mechanisms of the pharmacological activity of
flavonoids. Rus J Biopharm. 4:27–41. 2012.
|
|
9
|
Popov AM, Krivoshapko ON and Artyukov AA:
Comparative evaluation of the pharmacological activity of luteolin
and luteolin 7,3′-disulfate in modeling different pathologies. Rus
J Biopharm. 3:27–33. 2011.
|
|
10
|
Popov AM, Artyukov AA, Krivoshapko ON,
Krylova NV, Leonova GN and Kozlovskaja EP: Medication, processing
antioxidant, cardioprotective, antidiabetic, anti-inflammatory,
hepatoprotective, antitumoral and antiviral action. Patent Russian
Federation 2432959. 2011.
|
|
11
|
Gervois P, Fruchart JC and Staels B: Drug
Insight: Mechanisms of action and therapeutic applications for
agonists of peroxisome proliferator-activated receptors. Nat Clin
Pract Endocrinol Metab. 3:145–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mueller M, Lukas B, Novak J, Simoncini T,
Genazzani AR and Janqbauer A: Oregano: A source for peroxisome
proliferator-activated receptor gamma antagonists. J Agric Food
Chem. 56:11621–11630. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsybulsky AV, Popov AM and Artyukov AA:
The Comparative study of the medical action of lyuteolin,
rosmarinic acid and echinochrome A at experimental stress-induced
cardiovascular. Biomed Khim. 57:314–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu ZM, Hu M, Chan P and Tomlinson B:
Early investigational drugs targeting PPAR-α for the treatment of
metabolic disease. Expert Opin Investig Drugs. 24:611–621. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xagorari A, Papapetropoulos A, Mauromatis
A, Economou M, Fotsis T and Roussos C: Luteolin inhibits an
endotoxin-stimulated phosphorylation cascade and proinflammatory
cytokine production in macrophages. J Pharmacol Exp Ther.
296:181–187. 2001.PubMed/NCBI
|
|
16
|
Ding L, Jin D and Chen X: Luteolin
enhances insulin sensitivity via activation of PPARγ
transcriptional activity in adipocytes. J Nutr Biochem. 21:941–947.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park HS, Kim SH, Kim YS, Ryu SY, Hwang JT,
Yang HJ, Kim GH, Kwon DY and Kim MS: Luteolin inhibits adipogenic
differentiation by regulating PPARgamma activation. Biofactors.
35:373–379. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Puhl AC, Bernardes A, Silveira RL, Yuan J,
Campos JL, Saidemberg DM, Palma MS, Cvoro A, Ayers SD, Webb P, et
al: Mode of peroxisome proliferator-activated receptor γ activation
by luteolin. Mol Pharmacol. 81:788–799. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lopez-Lázaro M: Distribution and
biological activities of the flavonoid luteolin. Mini Rev Med Chem.
9:31–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kure A, Nakagawa K, Kondo M, Kato S,
Kimura F, Watanabe A, Shoji N, Hatanaka S, Tsushida T and Miyazawa
T: Metabolic fate of Luteolin in rats: Its relationship to
anti-inflammatory effect. J Agric Food Chem. 64:4246–4254. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gamo K, Shiraki T, Matsuura N and Miyachi
H: Mechanism of peroxisome proliferator-activated receptor gamma
(PPARγ) transactivation by hesperetin glucuronides is distinct from
that by a thiazolidine-2,4-dione agent. Chem Pharm Bull (Tokyo).
62:491–493. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weidner C, Wowro SJ, Freiwald A, Kodelja
V, Abdel-Aziz H, Kelber O and Sauer S: Lemon balm extract causes
potent antihyperglycemic and antihyperlipidemic effects in
insulin-resistant obese mice. Mol Nutr Food Res. 58:903–907. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Molavi B, Rassouli N, Bagwe S and Rasouli
N: A review of thiazolidinediones and metformin in the treatment of
type 2 diabetes with focus on cardiovascular complications. Vasc
Health Risk Manag. 3:967–973. 2007.PubMed/NCBI
|
|
24
|
Lien EJ, Ren S, Bui HH and Wang R:
Quantitative structure-activity relationship analysis of phenolic
antioxidants. Free Radic Biol Med. 26:285–294. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nimnual AS, Taylor LJ and Bar-Sagi D:
Redox-dependent downregulation of Rho by Rac. Nat Cell Biol.
5:236–241. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Popov AM, Krivoshapko ON, Klimovich AA and
Artyukov AA: Biological activity and mechanisms of therapeutic
action of rosmarinic acid, luteolin and its sulphated derivatives.
Biomed Khim. 62:22–30. 2016.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Popov AM, Osipov AN, Korepanova EA,
Krivoshapko ON, Artyukov AA and Klimovich AA: Study of antioxidant
and membrane activity of luteoline using different model systems.
Biophysics (Russian Federation). 61:1079–1087. 2016.
|
|
28
|
Nagao A, Seki M and Kobayashi H:
Inhibition of xanthine oxidase by flavonoids. Biosci Biotechnol
Biochem. 63:1787–1790. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sen N, Das BB, Ganguly A, Banerjee B, Sen
T and Majumder HK: Leishmania donovani: Intracellular ATP level
regulates apoptosis-like death in luteolin induced dyskinetoplastid
cells. Exp Parasitol. 114:204–214. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Manju V and Nalini N: Chemopreventive
potential of luteolin during colon carcinogenesis induced by
1,2-dimethylhydrazine. Ital J Biochem. 54:268–275. 2005.PubMed/NCBI
|
|
31
|
Robak J, Shridi F, Wolbís M and
Królikowska M: Screening of the influence of flavonoids on
lipoxygenase and cyclooxygenase activity, as well as on nonenzymic
lipid oxidation. Pol J Pharmacol Pharm. 40:451–458. 1988.PubMed/NCBI
|
|
32
|
Paredes-Gonzalez X, Fuentes F, Jeffery S,
Saw CL, Shu L, Su ZY and Kong AN: Induction of Nrf2-mediated gene
expression by dietary phytochemical flavones apigenin and luteolin.
Biopharm Drug Dispos. 36:440–451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brown JE and Rice-Evans CA: Luteolin-rich
artichoke extract protects low density lipoprotein from oxidation
in vitro. Free Radic Res. 29:247–255. 1988. View Article : Google Scholar
|
|
34
|
Popov AM, Osipov AN, Korepanova EA,
Krivoshapko ON and Artyukov AA: Study of antioxidant and membrane
activity of rosmarinic acid using different model systems.
Biofizika. 58:775–785. 2013.(In Russian). PubMed/NCBI
|
|
35
|
Sotnikova R, Okruhlicova L, Vlkovicova J,
Navarova J, Gajdacova B, Pivackova L, Fialova S and Krenek P:
Rosmarinic acid administration attenuates diabetes-induced vascular
dysfunction of the rat aorta. J Pharm Pharmacol. 65:713–723. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Harris GK, Qian Y, Leonard SS, Sbarra DC
and Shi X: Luteolin and chrysin differentially inhibit
cyclooxygenase-2 expression and scavenge reactive oxygen species
but similarly inhibit prostaglandin-E2 formation in RAW 264.7
cells. J Nutr. 136:1517–1521. 2006.PubMed/NCBI
|
|
37
|
Fadel O, El Kirat K and Morandat S: The
natural antioxidant rosmarinic acid spontaneously penetrates
membranes to inhibit lipid peroxidation in situ. Biochim Biophys
Acta. 1808:2973–2980. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kawai Y: Immunochemical detection of
food-derived polyphenols in the aorta: Macrophages as a major
target underlying the anti-atherosclerotic activity of polyphenols.
Biosci Biotechnol Biochem. 75:609–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee J, Jung E, Kim Y, Lee J, Park J, Hong
S, Hyun CG, Park D and Kim YS: Rosmarinic acid as a downstream
inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11
and CCR3. J Pharmacol. 148:366–375. 2006.
|
|
40
|
Ando C, Takahashi N, Hirai S, Nishimura K,
Lin S, Uemura T, Goto T, Yu R, Nakagami J, Murakami S and Kawada T:
Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent
activation of macrophages by inhibiting JNK activation. FEBS Lett.
583:3649–3654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hirai S, Takahashi N, Goto T, Lin S,
Uemura T, Yu R and Kawada T: Functional food targeting the
regulation of obesity-induced inflammatory responses and
pathologies. Mediators Inflamm. 2010:3678382010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Köhle C and Bock KW: Activation of coupled
Ah receptor and Nrf2 gene batteries by dietary phytochemicals in
relation to chemoprevention. Biochem Pharmacol. 72:795–805. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Govindaraj J and Pillai Sorimuthu S:
Rosmarinic acid modulates the antioxidant status and protects
pancreatic tissues from glucolipotoxicity mediated oxidative stress
in high-fat diet: Streptozotocin-induced diabetic rats. Mol Cell
Biochem. 404:143–159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hirsch HA, Ilipoulos D and Struhl K:
Metformin inhibits the inflammatory response associated with
cellular transformation and cancer stem cell growth. Proc Natl Acad
Sci USA. 110:972–977. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Watson JD: Types diabetes as a redox
disease. Lancet. 383:841–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ristow M, Zarse K, Oberbach A, Klöting N,
Birringer M, Kiehntopf M, Stumvoll M, Kahn CR and Blüher M:
Antioxidants prevent health-promoting effects of physical exercise
in humans. Proc Natl Acad Sci USA. 106:8665–8670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shi RX, Ong CN and Shen HM: Luteolin
sensitizes tumor necrosis factor-alpha-induced apoptosis in human
tumor cells. Oncogene. 23:7712–7721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ju W, Wang X, Shi H, Chen W, Belinsky SA
and Lin Y: A critical role of luteolin-induced reactive oxygen
species in blockage of tumor necrosis factor-activated nuclear
factor-kappaB pathway and sensitization of apoptosis in lung cancer
cells. Mol Pharmacol. 71:1381–1388. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mukinda JT, Syce JA, Fisher D and Meyer M:
Effect of the Plant Matrix on the Uptake of Luteolin
Derivatives-containing Artemisia afra Aqueous-extract in Caco-2
cells. J Ethnopharmacol. 130:439–449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hoshino J, Park EJ, Kondratyuk TP, Marler
L, Pezzuto JM, van Breemen RB, Mo S, Li Y and Cushman M: Selective
synthesis and biological evaluation of sulfate-conjugated
resveratrol metabolites. J Med Chem. 53:5033–5043. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Santner SJ, Feil PD and Santen RJ: In situ
estrogen production via estrone sulphatase pathway in breast
tumours: Relative importance versus the aromatase pathway. J Clin
Endocrinol Metab. 59:29–33. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Burckhardt G and Burckhardt BC: In vitro
and in vivo evidence of the importance of organic anion
transporters (OATs) in drug therapy. Handb Exp Pharmacol. 29–104.
2011. View Article : Google Scholar : PubMed/NCBI
|
